Treatment of Pulmonary Thromboembolism.

  • GOLDHABER Samuel Z.
    Cardiovascular Division, Department of Medicine Brigham and Women's Hospital, Harvard Medical School

この論文をさがす

抄録

The epidemiology, diagnosis, treatment, and prophylaxis of PE are rapidly advancing. Our array of diagnostic imaging tools has expanded to include echocardiography and spiral chest CT with contrast. We have also gained a keen appreciation for the importance of risk stratification of our patients. The decision to administer thrombolysis or undertake embolectomy may now depend upon the presence of right ventricular dysfunction even if systemic arterial pressure is normal. Finally, the availability of low molecular weight heparins broadens our options for pharmacologic management.<br>(Internal Medicine 38: 620-625, 1999)

収録刊行物

  • Internal Medicine

    Internal Medicine 38 (8), 620-625, 1999

    一般社団法人 日本内科学会

参考文献 (39)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ